TABLE 4.

Number of facilities providing for laboratory monitoring of HIV patients and scheduled frequency, by patient type, at 43 sites for which data were analyzed. Services included CD4 count testing, viral load testing, and blood and hematology testing.

Scheduled CD4 count tests:
Pre-ART patients
Every 3 months	14 of 43 (32.6%)
Every 6 months	19 of 43 (44.2%)
Baseline only, no routine testing	10 of 43 (23.3%)
Newly initiated adult ART patients* (first 6 months):
At baseline, every 3 months	24 of 41 (58.5%)
At baseline, every 6 months	14 of 41 (34.2%)
Baseline only, no routine testing	3 of 41 (7.3%)
Established adult ART patients* (after first 6 months):
Every 3 months	10 of 41 (24.4%)
Every 6 months	26 of 41 (63.4%)
Annually	1 of 41 (2.4%)
Nonroutine testing	4 of 41 (9.8%)
Scheduled blood chemistry and hematology tests:
Pre-ART patients
Every 3 months	7 of 43 (16.3%)
Every 6 months	13 of 43 (30.2%)
At baseline only	14 of 43 (32.6%)
Never	5 of 43 (11.6%)
Nonroutine testing	4 of 43 (9.3%)
Newly initiated adult ART patients* (first 6 months)
At baseline, every 3 months	25 of 41 (61.0%)
At baseline, every 6 months	11 of 41 (26.8%)
At baseline only	4 of 41 (9.8%)
Nonroutine testing	1 of 41 (2.4%)
Established adult ART patients* (after first 6 mo.)
Every 3 months	14 of 41 (34.2%)
Every 6 months	20 of 41 (48.8%)
Never	2 of 41 (4.9%)
Nonroutine testing	5 of 41 (12.2%)
Perform viral load tests:	14 of 43 (32.6%)

^*One facility in Uganda and one facility in Vietnam are pediatric facilities.